340B Podcast Series, Episode 3: A Deep Dive Into the Growth Drivers Behind the Recently Released 340B Program Purchase Numbers from HRSA with Clay Willis
In this episode, Clay Willis, Partner of Advisory Services at IntegriChain, unpacks the real forces behind 340B's continued growth, such as expanding patient definitions, telehealth referral models, contract pharmacy state access laws, and more. Also discussed are key market pressures on the horizon including IRA and Medicare pricing impacts and Part B reimbursement changes.
Listeners will come away with a better picture of what's fueling 340B program expansion where scrutiny is increasing, and what to watch for as HRSA prepares further updates.